What Is My Healthcare Business Worth? Understanding Healthcare Valuations

Every healthcare owner eventually asks the same question: what is my business actually worth? The answer is rarely a single number. It is a range defined by the quality of earnings, the durability of cash flow, and the specific characteristics buyers are pricing in your subsector today.

EBITDA — earnings before interest, taxes, depreciation, and amortization — is the starting point. It approximates the cash the business generates before capital structure and tax decisions. But buyers do not price on reported EBITDA. They price on adjusted EBITDA, which normalizes for owner compensation above market, personal expenses run through the business, non-recurring legal or consulting fees, one-time revenue events, and investments the buyer would not repeat. Adjustments must be defensible and documented; aggressive add-backs that cannot survive diligence are the most common reason deals reprice after LOI.

Valuation multiples vary widely across healthcare subsectors. Home health and hospice agencies typically transact at 5–8x adjusted EBITDA, with premium multiples for scaled operators with clean Medicare compliance histories. Behavioral health — particularly substance use disorder and autism services — has traded at 8–14x for platform assets with accreditations and multi-state footprints. Urgent care, once frothy, has settled into the 6–10x range depending on payer mix and market density. Imaging centers command 6–9x, with premium pricing for hospital-independent, multi-modality operators. Multi-site physician practices range from 5–10x, with dermatology, ophthalmology, orthopedics, and dental groups commanding the highest multiples. RCM and healthcare IT businesses can reach 10–15x when recurring revenue exceeds 80% and net revenue retention is strong.

Recurring revenue is the single most important valuation variable across every subsector. A business with 80% recurring, contracted revenue trades at a materially higher multiple than a comparable business dependent on transactional or referral-driven volume. Buyers pay for predictability.

Provider dependence is the second variable buyers scrutinize. A physician practice whose EBITDA depends on one or two producers carries concentration risk that repricing cannot resolve — it must be mitigated through provider contracts, non-competes, equity rollover, and management depth. The same logic applies to any owner-operator business: reducing dependence on the founder is often worth more than another year of EBITDA growth.

Reimbursement risk is priced directly into the multiple. Payer concentration, exposure to Medicare rate changes, dependence on a single state Medicaid contract, or reliance on out-of-network billing all compress valuation. A diversified payer mix with commercial, Medicare, Medicaid, and self-pay balance is worth a premium — and worth investing to build before going to market.

Growth opportunities matter, but only when they are credible and quantified. A buyer will underwrite the base business as it exists, then layer in growth for identified opportunities: de novo locations with sites already selected, service line expansions with clinical infrastructure in place, or contracted revenue that has not yet ramped. Speculative growth is discounted; documented growth is paid for.

The honest answer to "what is my business worth" is that it is worth what a qualified buyer, in a competitive process, is willing to pay after complete diligence. Everything before that is estimation. The best estimates come from advisors who see the market daily, know current buyer behavior in your specific subsector, and are willing to give you a range rather than a headline.